Belgium Pharmaceutical Market Size - Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

Belgium's pharmaceutical sector is a cornerstone of the country's industrial economy, with basic pharmaceutical products consistently ranking among the top three largest manufacturing industries by production value. The domestic market itself is valued at approximately $8.4 billion in 2025 and is expected to grow to $11.78 billion by 2031. Beyond the domestic market, Belgium's pharmaceutical industry is a major export engine, generating over $64 billion in pharmaceutical exports annually and attracting approximately $6.56 billion in research and development investment.

• •Domestic market valued at $8.4 billion in 2025, projected to reach $11.78 billion by 2031 at 5.8% CAGR
• •Pharmaceutical products rank among Belgium's top three industrial sectors by production value
• •Industry generates over $64 billion in annual exports with $6.56 billion invested in R&D

Belgium's pharmaceutical market expansion is fueled by substantial R&D investment and its established position as a European pharmaceutical logistics and manufacturing hub. The broader pharmaceutical ecosystem is expanding rapidly, with pharmaceutical packaging alone valued at nearly $1.9 billion and logistics at $1.42 billion, both experiencing strong growth. Medical device testing services represent another high-growth segment projected to reach $110.8 million by 2030.

• •Approximately $6.56 billion in R&D investment supporting innovation and biopharmaceutical development
• •Pharmaceutical packaging market valued at $1.88 billion growing at 6.79% CAGR through 2032
• •Pharmaceutical logistics sector estimated at $1.42 billion with 8.47% CAGR

The Belgian pharmaceutical ecosystem extends beyond drug manufacturing to encompass specialized supporting industries including pharmaceutical packaging, logistics, and medical device testing. Pharmaceutical packaging represents a significant segment valued at nearly $1.9 billion in 2024 with a 6.79% CAGR, while pharmaceutical logistics is estimated at $1.42 billion with an 8.47% growth rate. Medical device testing services constitute a smaller but rapidly growing specialized segment projected at $110.8 million by 2030 with a 10.3% CAGR.

• •Pharmaceutical packaging valued at $1.88 billion in 2024, expanding at 6.79% CAGR
• •Pharmaceutical logistics market estimated at $1.42 billion in 2025 with 8.47% projected growth
• •Medical device testing services projected to reach $110.8 million by 2030 at 10.3% CAGR

What are the recent trends and outlook?

The Belgian pharmaceutical market is positioned for sustained growth through 2031, with the sector benefiting from increased specialization in biopharmaceuticals and expanding cold chain logistics capabilities. Ancillary markets such as pharmaceutical packaging and medical device testing are expected to outpace core market growth, with segments showing CAGR rates of 6.79% and 10.3% respectively. The overall industry's trajectory reflects broader European trends toward pharmaceutical supply chain resilience, advanced manufacturing, and increased R&D intensity.

• •Core market forecast to grow from $8.4 billion to $11.78 billion by 2031 at 5.8% CAGR
• •Ancillary sectors (packaging, logistics, testing) expected to grow faster than core pharmaceutical market
• •Industry benefiting from biopharmaceutical specialization and supply chain resilience investments